PRIMARY IMMUNODEFICIENCY IN BELARUS: FIRST REPORT OF THE NATIONAL REGISTRY OF PID

2016 ◽  
Author(s):  
Tatjana Uglova
Keyword(s):  
Primary Immunodeficiency ◽  
National Registry ◽  
First Report

scholarly journals Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry

2020 ◽  
Author(s):  
Jing Pang ◽  
David R. Sullivan ◽  
David L. Hare ◽  
David M. Colquhoun ◽  
Timothy R. Bates ◽  
...  
Keyword(s):  
Familial Hypercholesterolaemia ◽  
National Registry ◽  
First Report

Autoimmune and Inflammatory Manifestations in 247 Patients with Primary Immunodeficiency—a Report from the Slovenian National Registry

2016 ◽  
Vol 36 (8) ◽  
pp. 764-773 ◽  
Author(s):  
Štefan Blazina ◽  
Gašper Markelj ◽  
Anja Koren Jeverica ◽  
Nataša Toplak ◽  
Nevenka Bratanič ◽  
...  
Keyword(s):  
Primary Immunodeficiency ◽  
National Registry

scholarly journals Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency

2020 ◽  
Author(s):  
Samaneh Delavari ◽  
Hassan Abolhassani ◽  
Farhad Abolnezhadian ◽  
Fateme Babaha ◽  
Sara Iranparast ◽  
...  
Keyword(s):  
Stem Cell ◽  
Primary Immunodeficiency ◽  
Pediatric Patients ◽  
Immune Dysregulation ◽  
National Registry ◽  
Combined Immunodeficiency ◽  
Hematopoietic Stem ◽  
Immunomodulatory Agents ◽  
Different Types ◽  
Life Threatening

AbstractAlthough it is estimated that COVID-19 life-threatening conditions may be diagnosed in less than 1:1000 infected individuals below the age of 50, but the real impact of this pandemic on pediatric patients with different types of primary immunodeficiency (PID) is not elucidated. The current prospective study on a national registry of PID patients showed that with only 1.23 folds higher incidence of infections, these patients present a 10-folds higher mortality rate compared to population mainly in patients with combined immunodeficiency and immune dysregulation. Therefore, further management modalities against COVID-19 should be considered to improve the survival rate in these two PID entities using hematopoietic stem cell transplantation and immunomodulatory agents.

Primary Immunodeficiency Disorders in Iran: Update and New Insights from the Third Report of the National Registry

2014 ◽  
Vol 34 (4) ◽  
pp. 478-490 ◽  
Author(s):  
Asghar Aghamohammadi ◽  
Payam Mohammadinejad ◽  
Hassan Abolhassani ◽  
Babak Mirminachi ◽  
Masoud Movahedi ◽  
...  
Keyword(s):  
Primary Immunodeficiency ◽  
National Registry ◽  
Primary Immunodeficiency Disorders ◽  
The Third

scholarly journals Epidemiological characteristics and outcomes of SARS-CoV-2 infection in patients with rheumatic diseases: first report from the Argentine SAR-COVID registry

2021 ◽  
pp. 7-15
Author(s):  
Carolina A. Isnardi ◽  
Gimena Gómez ◽  
Rosana Quintana ◽  
Karen Roberts ◽  
Guillermo Berbotto ◽  
...  
Keyword(s):  
Rheumatic Disease ◽  
Latin American ◽  
Rheumatic Diseases ◽  
Clinical Characteristics ◽  
Wide Distribution ◽  
National Registry ◽  
Immunomodulatory Treatment ◽  
First Report ◽  
Epidemiological Characteristics ◽  
The Impact

In order to assess the impact of SARS-CoV-2 infection in patients with rheumatic diseases, the Argentine Society of Rheumatology has developed the National Registry of Patients with Rheumatic Diseases and COVID-19 (SAR-COVID). The aim of this study was to evaluate the sociodemographic and clinical characteristics of patients with rheumatic diseases and SARS-CoV-2 infection included in the SAR-COVID registry and to describe the complications and outcomes of COVID-19 in this population. Methods: SAR-COVID is a national, multicenter and observational registry, in which patients ≥18 years of age, with a diagnosis of a rheumatic disease who had SARS-CoV-2 infection are consecutively included. Sociodemographic data, comorbidities, underlying rheumatic disease and treatment, clinical characteristics, complications, laboratory and treatment of the SARS-CoV-2 infection were recorded. Results: a total of 525 patients were included, with a mean age of 51.3 years (SD 15.2). The most frequent rheumatic diseases were rheumatoid arthritis (40.4%), systemic lupus erythematous (14.9%) and spondyloarthritis (8.2%). At the time of the infection, 72.9% were receiving immunosuppressive or immunomodulatory treatment and 36.9% glucocorticoids. Most of the patients were diagnosed using RT-PCR (95%), at outpatient consultation (39.4%), at the emergency room (32.2%) or during hospitalization (14.7%). Symptoms were present in 96% of the patients, the most frequent being fever (56.2%), cough (46.7%) and headache (39.2%). During infection, 35.1% were hospitalized, 11.6% were admitted to the ICU and 6.9% died due to COVID-19. Most of them (75.1%) recovered completely. Conclusions: in this first report of the SAR-COVID registry we found a wide distribution of rheumatic diseases. Most of the patients had a good evolution of the infection, however 7% died as a result of it, comparable to other Latin American registries with similar populations.

A fossil Aspergillus from Eocene Dominican amber

1988 ◽  
Vol 62 (01) ◽  
pp. 141-143 ◽  
Author(s):  
Gerard M. Thomas ◽  
George O. Poinar
Keyword(s):  
Dominican Republic ◽  
Fossil Species ◽  
First Report ◽  
Dominican Amber ◽  
Eocene Amber

A sporulating Aspergillus is described from a piece of Eocene amber originating from the Dominican Republic. The Aspergillus most closely resembles a form of the white spored phase of Aspergillus janus Raper and Thom. This is the first report of a fossil species of Aspergillus.

Sign in / Sign up

Export Citation Format

Share Document